3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
55
Myelodysplastic Syndromes
32
Leukemia
18
Leukemia, Myelomonocytic, Chronic
11
Congenital Abnormalities
5
Recurrence
4
Neoplasms
4
Melanoma
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myeloproliferative Disorders
3
Leukemia, Megakaryoblastic, Acute
3
Leukemia, Erythroblastic, Acute
3
Carcinoma, Non-Small-Cell Lung
3
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Anemia, Refractory
2
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Thrombocytopenia
1
Thrombocythemia, Essential
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Primary Myelofibrosis
1
Interventions
Fulvestrant
4
Letrozole
2
Goserelin
2
Docetaxel
2
Dasatinib
2
vandetanib
1
sonidegib
1
pembrolizumab
1
palbociclib
1
olaparib
1
exemestane
1
cediranib
1
Lead
1
Gemcitabine
1
Everolimus
1
Capecitabine
1
Alpelisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Advanced Breast Cancer
×
Decitabine
×
Clear all
No trials found.